Chemical approaches to angiogenesis

Methods in Cell Biology

Volumn 2004, Issue 76, 2004, Pages 475-487

  Chan, Joanne ^a   Serluca, Fabrizio C ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOGENESIS INHIBITOR; GREEN FLUORESCENT PROTEIN; PROTEIN TYROSINE KINASE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; FLUORESCENCE ANGIOGRAPHY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; METHODOLOGY; MUTATION; PHENOTYPE; PHYSIOLOGY; PRENATAL DEVELOPMENT; STAINING; TRANSGENIC ANIMAL; VASCULAR ENDOTHELIUM; ZEBRA FISH;

ALKALINE PHOSPHATASE; ANGIOGENESIS INHIBITORS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; FLUORESCEIN ANGIOGRAPHY; GREEN FLUORESCENT PROTEINS; MUTATION; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; STAINING AND LABELING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZEBRAFISH;

EID: 16644394551     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0091-679x(04)76021-5     Document Type: Review

References (41)

1. Bold, G., Altmann, K. H., Frei, J., Lang, M., Manley, P. W., Traxler, P., Wietfeld, B., Bruggen, J., Buchdunger, E., Cozens, R., Ferrari, S., Furet, P., Hofmann, F., Martiny-Baron, G., Mestan, J., Rosel, J., Sills, M., Stover, D., Acemoglu, F., Boss, E., Emmenegger, R., Lasser, L., Masso, E., Roth, R., Schlachter, C., and Vetterli, W. (2000). New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis. J. Med. Chem. 43, 2310-2323.
2. Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.
3. Chan, J., Bayliss, P. E., Wood, J. M., and Roberts, T. M. (2002). Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 1, 257-267.
4. Chen, J. N., van Bebber, F., Goldstein, A. M., Serluca, F. C., Jackson, D., Childs, S., Serbedzija, G., Warren, K. S., Mably, J. D., Lindahl, P., Mayer, A., Haffter, P., and Fishman, M. C. (2001). Genetic steps to organ laterality in zebrafish. Comp. Funct. Genom. 2, 60-68.
5. Childs, S., Chen, J. N., Garrity, D. M., and Fishman, M. C. (2002). Patterning of angiogenesis in the zebrafish embryo. Development 129, 973-982.
6. Cross, L. M., Cook, M. A., Lin, S., Chen, J. N., and Rubinstein, A. L. (2003). Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler. Thromb. Vasc. Biol. 23, 911-912.
7. Dovey, H. F., John, V., Anderson, J. P., Chen, L. Z., de Saint Andrieu, P., Fang, L. Y., Freedman, S. B., Folmer, B., Goldbach, E., Holsztynska, E. J., Hu, K. L., Johnson-Wood, K. L., Kennedy, S. L., Kholodenko, D., Knops, J. E., Latimer, L. H., Lee, M., Liao, Z., Lieberburg, I. M., Motter, R. N., Mutter, L. C., Nietz, J., Quinn, K. P., Sacchi, K. L., Seubert, P. A., Shopp, G. M., Thorsett, E. D., Tung, J. S., Wu, J., Yang, S., Yin, C. T., Schenk, D. B., May, P. C., Altstiel, L. D., Bender, M. H., Boggs, L. N., Britton, T. C., Clemens, J. C., Czilli, D. L., Dieckman-McGinty, D. K., Droste, J. J., Fuson, K. S., Gitter, B. D., Hyslop, P. A., Johnstone, E. M., Li, W. Y., Little, S. P., Mabry, T. E., Miller, F. D., and Audia, J. E. (2001). Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J. Neurochem. 76, 173-181.
8. Drevs, J., Hofmann, I., Hugenschmidt, H., Wittig, C., Madjar, H., Muller, M., Wood, J., Martiny-Baron, G., Unger, C., and Marme, D. (2000). Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res. 60, 4819-4824.
9. Druker, B. J. (2002). STI571 (Gleevec) as a paradigm for cancer therapy. Trends Mol. Med. 8, S14-S18.
10. Folkman, J. (1971). Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285, 1182-1186.
11. Geling, A., Steiner, H., Willem, M., Bally-Cuif, L., and Haass, C. (2002). A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep. 3, 688-694.
12. Habeck, H., Odenthal, J., Walderich, B., Maischein, H., and Schulte-Merker, S. (2002). Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis. Curr. Biol. 12, 1405-1412.
13. Haffter, P., Granato, M., Brand, M., Mullins, M. C., Hammerschmidt, M., Kane, D. A., Odenthal, J., van Eeden, F. J., Jiang, Y. J., Heisenberg, C. P., Kelsh, R. N., Furutani-Seiki, M., Vogelsang, E., Beuchle, D., Schach, U., Fabian, C., and Nusslein-Volhard, C. (1996). The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123, 1-36.
14. Isogai, S., Horiguchi, M., and Weinstein, B. M. (2001). The vascular anatomy of the developing zebrafish: An atlas of embryonic and early larval development. Dev. Biol. 230, 278-301.
15. Isogai, S., Lawson, N. D., Torrealday, S., Horiguchi, M., and Weinstein, B. M. (2003). Angiogenic network formation in the developing vertebrate trunk. Development 130, 5281-5290.
16. Juttermann, R., Li, E., and Jaenisch, R. (1994). Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl. Acad. Sci. USA 91, 11797-11801.
17. Kantarjian, H. M., and Talpaz, M. (2001). Imatinib mesylate: Clinical results in Philadelphia chromosome-positive leukemias. Semin. Oncol. 28, 9-18.
18. Lawson, N. D., and Weinstein, B. M. (2002a). Arteries and veins: Making a difference with zebrafish. Nat. Rev. Genet. 3, 674-682.
19. Lawson, N. D., and Weinstein, B. M. (2002b). In Vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248, 307-318.
20. Manley, P. W., Martiny-Baron, G., Schlaeppi, J. M., and Wood, J. M. (2002). Therapies directed at vascular endothelial growth factor. Expert Opin. Investig. Drugs 11, 1715-1736.
21. Martin, C. C., Laforest, L., Akimenko, M. A., and Ekker, M. (1999). A role for DNA methylation in gastrulation and somite patterning. Dev. Biol. 206, 189-205.
22. Matsumoto, T., and Claesson-Welsh, L. (2001). VEGF receptor signal transduction. Sd. STKE. 2001, RE21.
23. Milan, D. J., Peterson, T. A., Ruskin, J. N., Peterson, R. T., and MacRae, C. A. (2003). Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107, 1355-1358.
24. Nasevicius, A., Larson, J., and Ekker, S. C. (2000). Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast 17, 294-301.
25. Nüsslein-Volhard, C., and Dahm, R. (2002). "Zebrafish." Oxford University Press, New York.
26. Ozaki, H., Seo, M. S., Ozaki, K., Yamada, H., Yamada, E., Okamoto, N., Hofmann, F., Wood, J. M., and Campochiaro, P. A. (2000). Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am. J. Pathol. 156, 697-707.
27. Peterson, R. T., Link, B. A., Dowling, J. E., and Schreiber, S. L. (2000). Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc. Natl. Acad. Sci. USA 97, 12965-12969.
28. Peterson, R. T., Mably, J. D., Chen, J. N., and Fishman, M. C. (2001). Convergence of distinct pathways to heart patterning revealed by the small molecule concentramide and the mutation heart-and-soul. Curr. Biol. 11, 1481-1491.
29. Ransom, D. G., Haffter, P., Odenthal, J., Brownlie, A., Vogelsang, E., Kelsh, R. N., Brand, M., van Eeden, F. J., Furutani-Seiki, M., Granato, M., Hammerschmidt, M., Heisenberg, C. P., Jiang, Y. J., Kane, D. A., Mullins, M. C., and Nusslein-Volhard, C. (1996). Characterization of zebrafish mutants with defects in embryonic hematopoiesis. Development 123, 311-319.
30. Romanul, F. C., and Bannister, R. G. (1962). Localized areas of high alkaline phosphatase activity in endothelium of arteries. Nature 195, 611-612.
31. Schlessinger, J. (2000). Cell signaling by receptor tyrosine kinases. Cell 103, 211-225.
32. Schulte-Merker, S. (2002). Looking at embryos. In "Zebrafish" (C. Nusslein-Volhard and R. Dahm, eds.), pp. 39-58. Oxford University Press, New York.
33. Serbedzija, G. N., Flynn, E., and Willett, C. E. (1999). Zebrafish angiogenesis: A new model for drug screening. Angiogenesis 3, 353-359.
34. Simon, M. A., Bowtell, D. D., Dodson, G. S., Laverty, T. R., and Rubin, G. M. (1991). Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. Cell 67, 701-716.
35. St Johnston, D. (2002). The art and design of genetic screens: Drosophila melanogaster. Nat. Rev. Genet. 3, 176-188.
36. Stolk, A. (1963). Localized areas of high alkaline phosphatase activity in the endothelium of arteries in the axolotl. Experientia 19, 21.
37. Weinstein, B. M., Schier, A. F., Abdelilah, S., Malicki, J., Solnica-Krezel, L., Stemple, D. L., Stainier, D. Y., Zwartkruis, F., Driever, W., and Fishman, M. C. (1996). Hematopoietic mutations in the zebrafish. Development 123, 303-309.
38. Weinstein, B. M., Stemple, D. L., Driever, W., and Fishman, M. C. (1995). Gridlock, a localized heritable vascular patterning defect in the zebrafish. Nat. Med. 1, 1143-1147.
39. Wood, J. M., Bold, G., Buchdunger, E., Cozens, R., Ferrari, S., Frei, J., Hofmann, F., Mestan, J., Mett, H., O'Reilly, T., Persohn, E., Rosel, J., Schnell, C., Stover, D., Theuer, A., Towbin, H., Wenger, F., Woods-Cook, K., Menrad, A., Siemeister, G., Schirner, M., Thierauch, K. H., Schneider, M. R., Drevs, J., Martiny-Baron, G., and Totzke, F. (2000). PTK787/ZK. 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 60, 2178-2189.
40. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.
41. Zhong, T. P., Childs, S., Leu, J. P., and Fishman, M. C. (2001). Gridlock signalling pathway fashions the first embryonic artery. Nature 414, 216-220.